Activation of the cell stress kinase PKR in Alzheimer's disease and human amyloid precursor protein transgenic mice

Neurobiology of Disease

Volumn 14, Issue 1, 2003, Pages 52-62

  Peel, Alyson L ^a   Bredesen, Dale E ^a  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

Alzheimer's disease; Cell stress kinase; Histopathology; PKR; Plaques

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CELL STRESS KINASE PKR; ENZYME ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; PROTEIN SERINE THREONINE KINASE; SYNAPTOPHYSIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME PHOSPHORYLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; NERVE CELL; NEURITE; NEUROPATHY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SENILE PLAQUE; TISSUE DISTRIBUTION; TISSUE SECTION; TRANSGENIC MOUSE;

EID: 0041833464     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-9961(03)00086-X     Document Type: Article

References (54)

1. Adams J.C. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J. Histochem. Cytochem. 40:1992;1457-1463.
2. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging. 21:2000;383-421.
3. Arendt T. Alzheimer's disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain. Neurobiol. Aging. 21:2000;783-796.
4. Arendt T., Holzer M., Gartner U. Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease. J. Neural Transm. 105:1998;949-960.
5. Arendt T., Holzer M., Gartner U., Bruckner M.K. Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease. J. Neural Transm. Suppl. 54:1998;147-158.
6. Arendt T., Rodel L., Gartner U., Holzer M. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport. 7:1996;3047-3049.
7. Atzori C., Ghetti B., Piva R., Srinivasan A.N., Zolo P., Delisle M.B., Mirra S.S., Migheli A. Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. J. Neuropathol. Exp. Neurol. 60:2001;1190-1197.
8. Bancher C., Leitner H., Jellinger K., Eder H., Setinek U., Fischer P., Wegiel J., Wisniewski H.M. On the relationship between measles virus and Alzheimer neurofibrillary tangles in subacute sclerosing panencephalitis. Neurobiol. Aging. 17:1996;527-533.
9. Busser J., Geldmacher D.S., Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J. Neurosci. 18:1998;2801-2807.
10. Chang R.C., Suen K.C., Ma C.H., Elyaman W., Ng H.K., Hugon J. Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration. J. Neurochem. 83:2002;1215-1225.
11. Chang R.C., Wong A.K., Ng H.K., Hugon J. Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease. NeuroReport. 13:2002;2429-2432.
12. Cuddihy A.R., Wong A.H., Tam N.W., Li S., Koromilas A.E. The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro. Oncogene. 18:1999;2690-2702.
13. Dagon Y., Dovrat S., Vilchik S., Hacohen D., Shlomo G., Sredni B., Salzberg S., Nir U. Double-stranded RNA-dependent protein kinase, PKR, down-regulates CDC2/cyclin B1 and induces apoptosis in non-transformed but not in v-mos transformed cells. Oncogene. 20:2001;8045-8056.
14. Deatly A.M., Haase A.T., Fewster P.H., Lewis E., Ball M.J. Human herpes virus infections and Alzheimer's disease. Neuropathol. Appl. Neurobiol. 16:1990;213-223.
15. Dobson C.B., Itzhaki R.F. Herpes simplex virus type 1 and Alzheimer's disease. Neurobiol Aging. 20:1999;457-465.
16. Ferrante P., Caldarelli-Stefano R., Omodeo-Zorini E., Vago L., Boldorini R., Costanzi G. PCR detection of JC virus DNA in brain tissue from patients with and without progressive multifocal leukoencephalopathy. J. Med. Virol. 47:1995;219-225.
17. Ferrer I., Blanco R., Carmona M., Puig B. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. J. Neural Transm. 108:2001;1397-1415.
18. Gerst J.L., Raina A.K., Pirim I., McShea A., Harris P.L., Siedlak S.L., Takeda A., Petersen R.B., Smith M.A. Altered cell-matrix associated ADAM proteins in Alzheimer disease. J. Neurosci. Res. 59:2000;680-684.
19. Goedert M., Hasegawa M., Jakes R., Lawler S., Cuenda A., Cohen P. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Lett. 409:1997;57-62.
20. Goh K.C., deVeer M.J., Williams B.R. The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J. 19:2000;4292-4297.
21. Hsia A.Y., Masliah E., McConlogue L., Yu G.Q., Tatsuno G., Hu K., Kholodenko D., Malenka R.C., Nicoll R.A., Mucke L. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA. 96:1999;3228-3233.
22. Iordanov M.S., Paranjape J.M., Zhou A., Wong J., Williams B.R., Meurs E.F., Silverman R.H., Magun B.E. Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus involvement of RNase L, protein kinase R, and alternative pathways . Mol. Cell. Biol. 20:2000;617-627.
23. Ito T., Yang M., May W.S. RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling. J. Biol. Chem. 274:1999;15427-15432.
24. Johnston J.B., Silva C., Holden J., Warren K.G., Clark A.W., Power C. Monocyte activation and differentiation augment human endogenous retrovirus expression implications for inflammatory brain diseases . Ann. Neurol. 50:2001;434-442.
25. Kurata S. Selective activation of p38 MAPK cascade and mitotic arrest caused by low level oxidative stress. J. Biol. Chem. 275:2000;23413-23416.
26. Lin W.R., Shang D., Itzhaki R.F. Neurotropic viruses and Alzheimer disease. Interaction of herpes simplex type 1 virus and apolipoprotein E in the etiology of the disease. Mol. Chem. Neuropathol. 28:1996;135-141.
27. Mucke L., Masliah E., Yu G.Q., Mallory M., Rockenstein E.M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., McConlogue L. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice synaptotoxicity without plaque formation . J. Neurosci. 20:2000;4050-4058.
28. Nagy Z., Esiri M.M., Cato A.M., Smith A.D. Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol. (Berl.). 94:1997;6-15.
29. Nagy Z., Esiri M.M., Smith A.D. Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol. (Berl.). 93:1997;294-300.
30. Nagy Z., Esiri M.M., Smith A.D. The cell division cycle and the pathophysiology of Alzheimer's disease. Neuroscience. 87:1998;731-739.
31. Okamoto K., Hirai S., Iizuka T., Yanagisawa T., Watanabe M. Reexamination of granulovacuolar degeneration. Acta Neuropathol. (Berl.). 82:1991;340-345.
32. Patel C.V., Handy I., Goldsmith T., Patel R.C. PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR. J. Biol. Chem. 275:2000;37993-37998.
33. Patel R.C., Sen G.C. PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J. 17:1998;4379-4390.
34. Peel A.L., Rao R.V., Cottrell B.A., Hayden M.R., Ellerby L.M., Bredesen D.E. Double-stranded RNA-dependent protein kinase, PKR, binds preferentially to Huntington's disease (HD) transcripts and is activated in HD tissue. Hum. Mol. Genet. 10:2001;1531-1538.
35. Raina A.K., Monteiro M.J., McShea A., Smith M.A. The role of cell cycle-mediated events in Alzheimer's disease. Int. J. Exp. Pathol. 80:1999;71-76.
36. Raina A.K., Pardo P., Rottkamp C.A., Zhu X., Pereira-Smith O.M., Smith M.A. Neurons in Alzheimer disease emerge from senescence. Mech. Ageing Dev. 123:2001;3-9.
37. Raina A.K., Zhu X., Monteiro M., Takeda A., Smith M.A. Abortive oncogeny and cell cycle-mediated events in Alzheimer disease. Prog. Cell Cycle Res. 4:2000;235-242.
38. Raina A.K., Zhu X., Rottkamp C.A., Monteiro M., Takeda A., Smith M.A. Cyclin' toward dementia cell cycle abnormalities and abortive oncogenesis in Alzheimer disease . J. Neurosci. Res. 61:2000;128-133.
39. Ruvolo P.P. Ceramide regulates cellular homeostasis via diverse stress signaling pathways. Leukemia. 15:2001;1153-1160.
40. Smith M.Z., Nagy Z., Esiri M.M. Cell cycle-related protein expression in vascular dementia and Alzheimer's disease. Neurosci. Lett. 271:1999;45-48.
41. Smith T.W., Lippa C.F. Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders. J. Neuropathol. Exp. Neurol. 54:1995;297-303.
42. Talloczy Z., Jiang W., Virgin H.I., Leib D.A., Scheuner D., Kaufman R.J., Eskelinen E.L., Levine B. Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway. Proc. Natl. Acad. Sci. USA. 99:2002;190-195.
43. Vincent I., Bu B., Hudson K., Husseman J., Nochlin D., Jin L. Constitutive Cdc25B tyrosine phosphatase activity in adult brain neurons with M phase-type alterations in Alzheimer's disease. Neuroscience. 105:2001;639-650.
44. Walker D.G., O'Kusky J.R., McGeer P.L. In situ hybridization analysis for herpes simplex virus nucleic acids in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 3:1989;123-131.
45. Williams B.R. PKR; a sentinel kinase for cellular stress. Oncogene. 18:1999;6112-6120.
46. Williams, B.R., 2001. Signal integration via PKR. Sci STKE 2001, RE2.
47. Xu M., Shibayama H., Kobayashi H., Yamada K., Ishihara R., Zhao P., Takeuchi T., Yoshida K., Inagaki T., Nokura K. Granulovacuolar degeneration in the hippocampal cortex of aging and demented patients - a quantitative study. Acta Neuropathol. (Berl.). 85:1992;1-9.
48. Yang Y., Geldmacher D.S., Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. J. Neurosci. 21:2001;2661-2668.
49. Zhu X., Raina A.K., Boux H., Simmons Z.L., Takeda A., Smith M.A. Activation of oncogenic pathways in degenerating neurons in Alzheimer disease. Int. J. Dev. Neurosci. 18:2000;433-437.
50. Zhu X., Rottkamp C.A., Boux H., Takeda A., Perry G., Smith M.A. Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J. Neuropathol. Exp. Neurol. 59:2000;880-888.
51. Zhu X., Raina A.K., Rottkamp C.A., Aliev G., Perry G., Boux H., Smith M.A. Activation and redistribution of c-Jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J. Neurochem. 76:2001;435-441.
52. Zhu X., Rottkamp C.A., Raina A.K., Brewer G.J., Ghanbari H.A., Boux H., Smith M.A. Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease. Neurobiol. Aging. 21:2000;807-813.
53. Zhu X., Rottkamp C.A., Hartzler A., Sun Z., Takeda A., Boux H., Shimohama S., Perry G., Smith M.A. Activation of MKK6, an upstream activator of p38, in Alzheimer's disease. J. Neurochem. 79:2001;311-318.
54. Zimmer C. Microbiology. Do chronic diseases have an infectious root. Science. 293:2001;1974-1977.